semaglutide and nonarteritic anterior ischemic optic neuropathy A comment on: “Risk of in patients prescribed semaglutide” | Journal of Diabetes & Metabolic Disorders Semaglutide and Tirzepatide Linked to

A defined off-period lets receptor density and sensitivity recover so the next cycle starts from a fresh baseline rather than a blunted one

In another study, an 84-week open-label trial with about 800 participants, people taking CagriSema had an average of 23% weight loss versus about 25 to 26% for tirzepatide (Zepbound) at the highest dose

Theres so much noise right now around peptides and biohacking in the health space Are they good

Glutathione is a little-known molecule that has become pivotal in advanced skincare

The true threat to the airway is the larynx and posterior tongue not the lips and anterior tongue

With 126 import alerts and the rollout of the Green List, the FDA has moved upstream